
Please try another search
As of April 30, 2024, Panaxia Labs Israel Ltd was acquired by Barak Investment House Ltd, in a reverse merger transaction. Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. Panaxia Labs Israel Ltd was incorporated in 2005 and is based in Lod, Israel.
Name | Age | Since | Title |
---|---|---|---|
Ephraim Lahav | 68 | 2023 | Chairman |
Bruch frilling | 55 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review